Extending Refugee Cash Assistance and Refugee Medical Assistance From 8 Months to 12 Months, 17312-17313 [2022-06356]
Download as PDF
<![CDATA[
17312
Federal Register / Vol. 87, No. 59 / Monday, March 28, 2022 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Initial Review Group; Career
Development Facilitating The Transition to
Independence Study Section.
Date: June 9–10, 2022.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging Gateway
Building 7201 Wisconsin Avenue Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: NIJAGUNA PRASAD,
Ph.D., Scientific Review Officer, Scientific
Review Branch, National Institute on Aging,
7201 Wisconsin Avenue, Gateway Bldg, Suite
2W200, Bethesda, MD 20892, (301) 496–
9667, prasadnb@nia.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Digestive Diseases
Research Core Centers (P30).
Date: July 14–15, 2022.
Time: 10:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
NIDDK, 6707 Democracy Blvd., Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Jian Yang, Ph.D., Scientific
Review Officer, Review Branch, Division of
Extramural Activities, NIDDK, National
Institutes of Health, Room 7011, 6707
Democracy Boulevard, Bethesda, MD 20892–
5452, (301) 594–7799 yangj@
extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: March 22, 2022.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–06376 Filed 3–25–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of Refugee Resettlement
Dated: March 22, 2022.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
Extending Refugee Cash Assistance
and Refugee Medical Assistance From
8 Months to 12 Months
[FR Doc. 2022–06372 Filed 3–25–22; 8:45 am]
AGENCY:
Office of Refugee Resettlement
(ORR), Administration for Children and
Families (ACF), Department of Health
and Human Services (HHS).
ACTION: Notice of change of eligibility
period.
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
VerDate Sep<11>2014
17:30 Mar 25, 2022
Jkt 256001
In accordance with ORR
regulations, the Director of ORR is
announcing the expansion of the
Refugee Cash Assistance (RCA) and
Refugee Medical Assistance (RMA)
eligibility period from 8 months to 12
months of assistance for participants
whose date of eligibility for ORR
benefits is on or after October 1, 2021.
Through the Refugee Act of 1980,
Congress authorized cash and medical
assistance up to 36 months, yet by fiscal
year (FY) 1992, mainly due to
insufficient appropriations, ORR had
SUMMARY:
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
jspears on DSK121TN23PROD with NOTICES1
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
reduced the RCA and RMA eligibility
periods to 8 months. For 30 years, ORR
has not increased the RCA or RMA
eligibility period. Extending the RCA
and RMA eligibility period will lead to
more effective resettlement, by
providing refugee and other ORReligible populations with additional
time to become self-sufficient.
DATES: The changes described in this
Federal Register notice are effective as
of the date of publication.
FOR FURTHER INFORMATION CONTACT:
Colleen Mahar-Piersma, Refugee Policy
Unit, Division of Policy and Procedures,
Office of the Director, Office of Refugee
Resettlement, Administration for
Children and Families, by phone at
(202) 260–5493, and email at
refugeepolicy@acf.hhs.gov.
SUPPLEMENTARY INFORMATION: The 1980
Refugee Act (8 U.S.C. 1522(e)(1))
authorized the Director of ORR
(hereinafter ‘‘the Director’’) to provide
RCA and RMA during the first 36
months after a refugee’s arrival in the
United States or, for other ORR-eligible
populations, after they became eligible
for ORR benefits and services. (ORReligible populations, hereinafter referred
to as ‘‘refugees,’’ are outlined within
ORR Policy Letter (PL) 16–01,
Documentation Requirements for the
Refugee Resettlement Program and ORR
PL 22–02, Additional ORR-Eligible
Statuses and Categories and Acceptable
Documentation Requirements for
Afghan Nationals.)
ORR regulations (45 CFR 400.211(a))
authorize the Director to determine the
time-eligibility period for RCA and
RMA each year based on the
appropriated funds available for the
fiscal year. After Congress passed the
Refugee Act of 1980, ORR provided
refugees with RCA and RMA for the first
36 months after a refugee’s arrival.
However, due to reduced
appropriations, ORR had to decrease
this assistance from 36 months to 18
months, then to 12 months, and finally,
in FY 1992, to 8 months.
The proposed expansion of the RCA
and RMA eligibility period would
positively impact refugees who are not
eligible for Temporary Assistance for
Needy Families or Medicaid. Increasing
the RCA and RMA eligibility period
enables refugees to address any medical
and mental health issues that would
impede their ability to become selfsufficient. Additionally, an expanded
eligibility period allows refugees to
focus on the Congressional priorities for
assistance, as outlined in the Refugee
Act, of acquiring English, receiving
employment training, and securing
employment, with the increase in
E:\FR\FM\28MRN1.SGM
28MRN1
Federal Register / Vol. 87, No. 59 / Monday, March 28, 2022 / Notices
English skills and professional
development potentially facilitating
employment at higher wagers, a benefit
not only for their families but for every
community where they reside.
Refugees whose date of eligibility for
ORR benefits is in FY 2022 (on or after
October 1, 2021) are eligible for the
expanded RCA and RMA eligibility
period.
(Authority: 45 CFR 400.211)
Dated: March 22, 2022.
Cindy Huang,
Director of the Office of Refugee Resettlement.
[FR Doc. 2022–06356 Filed 3–25–22; 8:45 am]
BILLING CODE 4120–27–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
jspears on DSK121TN23PROD with NOTICES1
Project: Mental and Substance Use
Disorders Prevalence Study (MDPS)
Grant Funded by SAMHSA, Grant
Number H79FG000030
SAMHSA is requesting from the
Office of Management and Budget
(OMB) approval to conduct recruitment
activities and clinical interviews with
household respondents and nonhousehold facilities and respondents as
part of the Mental and Substance Use
Disorders Prevalence Study (MDPS)
pilot program. Activities conducted will
include: A household rostering and
mental health screening of household
participants and a clinical interview of
both household and non-household
participants. The information gathered
by the clinical interview will be used to
determine prevalence estimates of
schizophrenia or schizoaffective
disorder; bipolar I disorder; major
depressive disorder; generalized anxiety
disorder; posttraumatic stress disorder
(PTSD); obsessive-compulsive disorder;
anorexia nervosa; and alcohol,
benzodiazepine, opioid, stimulant, and
cannabis use disorders among U.S.
adults ages 18 to 65 years.
17:30 Mar 25, 2022
Jkt 256001
The household rostering includes
inquiries about all adults ages 18 and
older residing in the household, to
assess eligibility for inclusion in the
study, and then selecting up to two
adults for the household mental health
screening. The total number of
household members and numbers of
adults and children are first asked,
followed by the first name, age and sex
of all adult household members, as well
as whether any adult in the household
has had a serious medical condition.
The best time to be interviewed is
collected as well. The computerized
roster can be completed online, by
phone, on paper, or in-person. The
target population is adults ages 18–65
residing in U.S. households; it is
estimated that 45,000 household rosters
will be completed. The primary
objective of the household roster is to
select up to two age-eligible participants
for the mental health screening
interview.
Household Mental Health Screening
Periodically, the Substance Abuse and
Mental Health Services Administration
(SAMHSA) will publish a summary of
information collection requests under
OMB review, in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
documents, call the SAMHSA Reports
Clearance Officer at (240) 276–0361.
VerDate Sep<11>2014
Household Rostering
The household mental health
screening interview utilizes the
Computerized Adaptive Testing for
Mental Health Disorders (CAT–MH) or
the World Health Organization’s
Composite International Diagnostic
Interview (CIDI) instruments to assess
symptoms related to the mental health
and substance use disorders of interest,
including schizophrenia or
schizoaffective disorder; bipolar I
disorder; major depressive disorder;
generalized anxiety disorder;
posttraumatic stress disorder (PTSD);
obsessive-compulsive disorder; anorexia
nervosa; and alcohol, benzodiazepine,
opioid, stimulant, and cannabis use.
The screening instrument also includes
questions on treatment, receipt of Social
Security Disability Income (SSDI),
military experience, and exposure to
and impact of COVID–19. The
computerized mental health screening
can be completed online, by phone, on
paper or in-person. The primary
objectives of the household mental
health screening interview are to assess
the symptoms endorsed and determine
eligibility and selection for the MDPS
pilot program clinical interview.
Clinical Interview
The MDPS pilot program clinical
interview includes questions that assess
the mental health and substance use
disorders using the NetSCID, a
computerized version of the Structured
Clinical Interview for DSM–V (SCID).
This instrument includes questions on
symptoms and their duration and
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
17313
frequency for the disorders of interest.
Also collected from respondents is
demographic information, including
sex, gender, age, education and
employment status. Hospitalization and
treatment history are asked as well as
questions to assess exposure to COVID–
19 of self or other close family members
and the impact on mental health. Up to
two adults per household will be
selected to complete the clinical
interview. Participants from the prisons,
jails, homeless shelters and state
psychiatric hospitals will complete the
clinical interview as well. The
computer-assisted personal interview
(CAPI) is administered by a trained
clinical interviewer, and can be
conducted by video conference, such as
Zoom or WebEx, phone or in person.
Approximately 7,200 clinical interviews
will be conducted as part of the MDPS
pilot program. The primary objective of
the clinical interview is to estimate the
prevalence of the disorders of interest,
including schizophrenia or
schizoaffective disorder; bipolar I
disorder; major depressive disorder;
generalized anxiety disorder;
posttraumatic stress disorder (PTSD);
obsessive-compulsive disorder; anorexia
nervosa; and alcohol, benzodiazepine,
opioid, stimulant, and cannabis use, as
well as unmet treatment needs.
Jail Mental Health Screening
The jail mental health screening
interview utilizes the CIDI screening
instruments to assess symptoms related
to the primary mental health and
substance use disorders of interest
including schizophrenia or
schizoaffective disorder; bipolar I
disorder; major depressive disorder;
generalized anxiety disorder;
posttraumatic stress disorder (PTSD);
obsessive-compulsive disorder; anorexia
nervosa; and alcohol, benzodiazepine,
opioid, stimulant, and cannabis use.
The screening instrument also includes
questions on treatment, receipt of Social
Security Disability Income (SSDI),
military experience, and exposure to
and impact of COVID–19. The
computerized mental health screening
will be completed in person or by
phone. The target population is a
convenience sample of incarcerated 18–
65-year-old adults, in up to six jails
identified by the MDPS co-investigator
team. Up to 208 mental health screening
interviews will be conducted among
incarcerated respondents. Respondents
will be provided with a card that
includes contact information and asked
to contact the project personnel when
they are released for inclusion in the
household clinical interview sample.
The primary objective of the jail mental
E:\FR\FM\28MRN1.SGM
28MRN1
]]>Agencies
[Federal Register Volume 87, Number 59 (Monday, March 28, 2022)]
[Notices]
[Pages 17312-17313]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-06356]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Office of Refugee Resettlement
Extending Refugee Cash Assistance and Refugee Medical Assistance
From 8 Months to 12 Months
AGENCY: Office of Refugee Resettlement (ORR), Administration for
Children and Families (ACF), Department of Health and Human Services
(HHS).
ACTION: Notice of change of eligibility period.
-----------------------------------------------------------------------
SUMMARY: In accordance with ORR regulations, the Director of ORR is
announcing the expansion of the Refugee Cash Assistance (RCA) and
Refugee Medical Assistance (RMA) eligibility period from 8 months to 12
months of assistance for participants whose date of eligibility for ORR
benefits is on or after October 1, 2021. Through the Refugee Act of
1980, Congress authorized cash and medical assistance up to 36 months,
yet by fiscal year (FY) 1992, mainly due to insufficient
appropriations, ORR had reduced the RCA and RMA eligibility periods to
8 months. For 30 years, ORR has not increased the RCA or RMA
eligibility period. Extending the RCA and RMA eligibility period will
lead to more effective resettlement, by providing refugee and other
ORR-eligible populations with additional time to become self-
sufficient.
DATES: The changes described in this Federal Register notice are
effective as of the date of publication.
FOR FURTHER INFORMATION CONTACT: Colleen Mahar-Piersma, Refugee Policy
Unit, Division of Policy and Procedures, Office of the Director, Office
of Refugee Resettlement, Administration for Children and Families, by
phone at (202) 260-5493, and email at [email protected].
SUPPLEMENTARY INFORMATION: The 1980 Refugee Act (8 U.S.C. 1522(e)(1))
authorized the Director of ORR (hereinafter ``the Director'') to
provide RCA and RMA during the first 36 months after a refugee's
arrival in the United States or, for other ORR-eligible populations,
after they became eligible for ORR benefits and services. (ORR-eligible
populations, hereinafter referred to as ``refugees,'' are outlined
within ORR Policy Letter (PL) 16-01, Documentation Requirements for the
Refugee Resettlement Program and ORR PL 22-02, Additional ORR-Eligible
Statuses and Categories and Acceptable Documentation Requirements for
Afghan Nationals.)
ORR regulations (45 CFR 400.211(a)) authorize the Director to
determine the time-eligibility period for RCA and RMA each year based
on the appropriated funds available for the fiscal year. After Congress
passed the Refugee Act of 1980, ORR provided refugees with RCA and RMA
for the first 36 months after a refugee's arrival. However, due to
reduced appropriations, ORR had to decrease this assistance from 36
months to 18 months, then to 12 months, and finally, in FY 1992, to 8
months.
The proposed expansion of the RCA and RMA eligibility period would
positively impact refugees who are not eligible for Temporary
Assistance for Needy Families or Medicaid. Increasing the RCA and RMA
eligibility period enables refugees to address any medical and mental
health issues that would impede their ability to become self-
sufficient. Additionally, an expanded eligibility period allows
refugees to focus on the Congressional priorities for assistance, as
outlined in the Refugee Act, of acquiring English, receiving employment
training, and securing employment, with the increase in
[[Page 17313]]
English skills and professional development potentially facilitating
employment at higher wagers, a benefit not only for their families but
for every community where they reside.
Refugees whose date of eligibility for ORR benefits is in FY 2022
(on or after October 1, 2021) are eligible for the expanded RCA and RMA
eligibility period.
(Authority: 45 CFR 400.211)
Dated: March 22, 2022.
Cindy Huang,
Director of the Office of Refugee Resettlement.
[FR Doc. 2022-06356 Filed 3-25-22; 8:45 am]
BILLING CODE 4120-27-P
